Target intelligence / Profile preview

BCAS1 antisense RNA 1 (BCAS1-AS1)

Target: BCAS1-AS1
Molecular classification: Long non-coding RNA (lncRNA)

Overview

BCAS1 antisense RNA 1 (BCAS1-AS1) is classified as a long non-coding RNA (lncRNA) encoded from a locus antisense to the BCAS1 gene on human chromosome 20 [5]. Its biological functions, disease associations, and therapeutic relevance remain uncharacterized in published literature as of now. There is no direct evidence that BCAS1-AS1 is a disease biomarker, drug target, or has roles in known biological pathways. BCAS1 (the sense gene) is well-studied in cancer and neuroscience, but the antisense transcript BCAS1-AS1 itself is not a known receptor, enzyme, transporter, or directly druggable target, nor is it considered a therapeutic target at present. The record should not be confused with BCAS1 (the protein-coding gene), which has a distinct and active literature.

Beyond the preview

Go deeper on BCAS1 antisense RNA 1 (BCAS1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BCAS1 antisense RNA 1 (BCAS1-AS1).

Explore the full profile